Phytochemistry, Anti-Diabetics And Anti-Cancer Properties Of Betula Utilis
Author(s):
Bhau Sandeep, Dr.Arti Chaurasia
Keywords:
phytochemicals, anticancer medication, anti-diabetic, cancer cells.
Abstract
The plant known as betula has a wide range of applications due to its adaptability and versatility. The D. Don tree, which is a member of the Betulaceae family and has a very long lifetime, has been referred to in Sanskrit for around four centuries as the Himalayan birch, bhojpatra, or Bhurja. This name comes from the fact that the D. Don tree is a member of the family Betulaceae. It is common known that the plant, when prepared in a medicinal form, has potential efficacy. A recent surge in attention in the use of birch bark as a possible therapy for cancer may be attributed to the high concentration of triterpenoids found in birch bark. These triterpenoids include betulinic acid and oleanolic acid, amongst others. Cancer cells are the target of the anticancer drug known as betulinic acid, which is responsible for their death. As a direct result of this, it set itself apart from several other alternative therapies for cancer. It has been shown that several species of the genus B. utilis contain both phenolic and flavonoid compounds. In addition to detecting the ability of phytochemicals to attach themselves to cancer cells, the SRB test is used to examine whether or not phytochemicals had anticancer properties when tested in a range of different solvents.
Article Details
Unique Paper ID: 156148
Publication Volume & Issue: Volume 9, Issue 2
Page(s): 39 - 48
Article Preview & Download
Share This Article
Conference Alert
NCSST-2023
AICTE Sponsored National Conference on Smart Systems and Technologies
Last Date: 25th November 2023
SWEC- Management
LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT